选择性血清素再吸收抑制剂用于中风恢复
Gillian Elizabeth Mead1, Cheng-Fang Hsieh, Maree Hackett
1Department of Geriatric Medicine, Royal Infirmary, Little France Crescent, Edinburgh, United Kingdom. Gillian.e.mead@ed.ac.uk
JAMA
|September 13, 2013
概括
选择性血清素再吸收抑制剂 (SSRI) 可能有助于中风恢复,即使没有抑郁症. 然而,目前的证据质量很低,需要进行大型试验来确认.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 临床神经学 临床神经学
背景情况:
- 脑卒中是导致长期残疾的主要原因.
- 确定有效的治疗方法对于中风后恢复至关重要.
- 抗抑郁药在非抑郁性中风幸存者的作用正在调查中.
研究的目的:
- 为了确定选择性血清素再吸收抑制剂 (SSRI) 是否能改善中风后的康复结果.
- 评估中风患者SSRI使用与功能恢复之间的关联.
主要方法:
- 现有研究的系统审查和元分析.
- 包括检查SSRI用于中风后恢复的试验.
- 评估研究质量和偏差风险.
主要成果:
- 初步发现表明,SSRI对中风恢复有潜在的益处.
- 观察到的恢复改善甚至在没有被诊断为抑郁症的患者中也被注意到.
- 发现了可用证据质量的显著异质和局限性.
结论:
- 兴奋剂可能与中风后更好的康复有关.
- 目前的证据基础在很大程度上质量不佳.
- 需要高质量的,大规模的随机对照试验来验证这些发现,并精确估计治疗效果.
更多相关视频
04:38A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
9.4K
06:15Effect of Yi-Nao-Jie-Yu Prescription on Post-Stroke Depression in Rats using Middle Cerebral Artery Occlusion Combined with Behavioral Restraint
Published on: January 9, 2026
209
相关概念视频
Antidepressant Drugs: Overview
2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.4K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.4K
Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Electroconvulsive Therapy
2.6K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.6K
